Global

Yamana Gold Inc. (AUY) is better stock pick than Pfizer Inc. (PFE)

The shares of Yamana Gold Inc. have increased by more than 7.05% this year alone. The shares recently went up by 5.03% or $0.16 and now trades at $3.34. The shares of Pfizer Inc. (NYSE:PFE), has jumped by 0.94% year to date as of 01/11/2018. The shares currently trade at $36.56 and have been able to report a change of -0.63% over the past one week.

The stock of Yamana Gold Inc. and Pfizer Inc. were two of the most active stocks on Thursday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 25.52% versus 5.90%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that AUY will grow it’s earning at a 25.52% annual rate in the next 5 years. This is in contrast to PFE which will have a positive growth at a 5.90% annual rate. This means that the higher growth rate of AUY implies a greater potential for capital appreciation over the years.



Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of AUY is -2.40% while that of PFE is 7.80%. These figures suggest that PFE ventures generate a higher ROI than that of AUY.

Cash Flow 




The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, AUY’s free cash flow per share is a negative -3.7, while that of PFE is positive 4.74.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for AUY is 1.00 and that of PFE is 1.40. This implies that it is easier for AUY to cover its immediate obligations over the next 12 months than PFE. The debt ratio of AUY is 0.43 compared to 0.72 for PFE. PFE can be able to settle its long-term debts and thus is a lower financial risk than AUY.

Valuation

AUY currently trades at a forward P/E of 25.30, a P/B of 0.70, and a P/S of 1.76 while PFE trades at a forward P/E of 13.28, a P/B of 3.58, and a P/S of 4.15. This means that looking at the earnings, book values and sales basis, AUY is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of AUY is currently at a -5.38% to its one-year price target of 3.53. Looking at its rival pricing, PFE is at a -4.52% relative to its price target of 38.29. This figure implies that over the next one year, PFE is a better investment.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), AUY is given a 2.70 while 2.50 placed for PFE. This means that analysts are more bullish on the outlook for AUY stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for AUY is 2.10 while that of PFE is just 3.92. This means that analysts are more bullish on the forecast for AUY stock.

Conclusion

The stock of Yamana Gold Inc. defeats that of Pfizer Inc. when the two are compared, with AUY taking 7 out of the total factors that were been considered. AUY happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, AUY is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for AUY is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

Which Market Offer More Value? – Retractable... The shares of Retractable Technologies, Inc. have increased by more than 48.53% this year alone. The shares recently went up by 6.32% or $0.06 and now...
BioAmber Inc. (BIOA) Sentiment Based on the Techni... BioAmber Inc. (NYSE:BIOA) gained 2.76% in yesterday’s session, going up from its prior closing price of $0.58 to $0.60 The stock price went upward in ...
Twilio Inc. (TWLO) vs. Pennsylvania Real Estate In... Twilio Inc. (NYSE:TWLO) shares are up more than 133.64% this year and recently increased 2.62% or $1.41 to settle at $55.14. Pennsylvania Real Estate ...
A Comparison of Top Movers: NetApp, Inc. (NTAP), Z... The shares of NetApp, Inc. have increased by more than 2.69% this year alone. The shares recently went down by -5.66% or -$3.41 and now trades at $56....
Which is more compelling pick right now? – M... The shares of MannKind Corporation have increased by more than 28.45% this year alone. The shares recently went up by 7.97% or $0.22 and now trades at...